Home / Intelligence / White Papers / Women Representation in Life Science Consulting Leadership
Over the past few years, there has been a spotlight on gender representation in leadership in a wide range of industries. Women are underrepresented in healthcare and biotech companies, despite evidence showing that companies that don’t have equitable representation perform worse compared to those that do.
While this is recognized, there is a lack of understanding about the scope of the problem within life sciences consulting. In general, there is a lack of transparency on these issues, with a resulting scarcity of accurate data.
Trinity Life Sciences conducted research to fill this knowledge gap and quantify the problem in our own industry. The lack of reliable data makes it difficult to establish overall industry benchmarks, identify particular areas of concern, and verify any claims being made. Wider and more accurate knowledge is necessary for effective leadership and decision-making on this issue.
Thank you for your interest. Continue reading the Trinity Whitepaper – Women Representation in Life Science Consulting Leadership below.
Related Intelligence
Webinars
Diversity in Clinical Trials: Evaluating Current Initiatives and the Impending Impact of the FDA’s Guidance
Available On Demand
Trinity’s Diversity, Equity & Inclusion (DEI) strategy team invites life sciences executives to join a lively discussion on recent research and developments in clinical trial diversity with a focus on racial and ethnic minorities. Herman Sanchez, Chief Business Officer at Trinity Life Sciences, will host this session and moderate a panel with special guests Monique […]
Watch Now
White Papers
Diversity in Clinical Trials: Life Sciences Initiatives and Challenges in Light of the FDA’s Latest Guidance
To date, life sciences’ efforts towards driving equitable healthcare have centered around access to care, early identification and prevention. Meanwhile, less attention has been given to the impact of the racial and ethnic homogeneity in trial populations. Clinical trial diversity continues to be one of the greatest challenges pharmaceutical and biotech companies face in ensuring […]
Read More
Podcasts
Measures the Life Sciences Industry Can Take to Facilitate Diversity in Clinical Trials
The importance of ensuring diversity in clinical trials is undisputed, but barriers across the healthcare ecosystem still exist; what can healthcare regulators, policy makers, and manufacturers do to overcome challenges when recruiting clinical trial participants? Host, Matthew Rube, a Senior Consultant at Trinity Life Sciences, joins two of the subject-matter experts that authored Trinity Life […]
Listen Now